Home
Company
Team
Investment Approach
For Entrepreneurs
Portfolio Companies
News & Events
Contact Us
Logo
At GBS, we're focused on one and only one mission: to help talented entrepreneurs build great life science technology companies.

Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio

08 / 11 / 2021

> Read More

5th FDA drug approval for the GBS Venture Partners portfolio

02 / 11 / 2020

> Read More

FDA Approves Bronchitol For US Market

02 / 11 / 2020

> Read More